• 1
    RiesLAG, EisnerMP, KosaryCL, HankeyBF, MillerBA, CleggL, MariottoA, FeuerEJ, EdwardsBK, editors. SEER cancer statistics review, 1975–2001. National Cancer Institute: Bethesda, MD. URL:, 2004.
  • 2
    Fiore MC. Trends in cigarette smoking in the United States. The epidemiology of tobacco use. Med Clin North Am. 1992;Mar 76(2): 289303.
  • 3
    National Center for Health Statistics. Data tables for figures 8.1–8.4. Available from [accession date: November 11, 2004]
  • 4
    Novotny TE, Warner KE, Kendrick JS, Remington PL. Smoking by blacks and whites: socioeconomic and demographic differences. Am J Public Health. 1988; 78: 11871189.
  • 5
    Watson JM, Scarinci IC, Klesges RC, Murray DM, Vander Weg M, DeBon M, et al. Relationships among smoking status, ethnicity, socioeconomic indicators, and lifestyle variables in a biracial sample of women. Prev Med. 2003; 37: 138147.
  • 6
    Kabat GC, Morabia A, Wynder EL. Comparison of smoking habits of blacks and whites in a case-control study. Am J Public Health. 1991; 81: 1483486.
  • 7
    Schwartz AG, Swanson GM. Lung carcinoma in African Americans and whites. A population-based study in metropolitan Detroit, Michigan. Cancer. 1997; 79: 4552.
  • 8
    Stellman SD, Chen Y, Muscat JE, Djordjevic MV, Richie JP Jr, Lazarus P, et al. Lung cancer risk in white and black Americans. Ann Epidemiol. 2003; 13: 294302.
  • 9
    Wagenknecht LE, Cutter GR, Haley NJ, Sidney S, Manolio TA, Hughes GH, et al. Racial differences in serum cotinine levels among smokers in the CARDIA Study. Am J Public Health. 1990; 80: 10531056.
  • 10
    Richie JP Jr, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomark Prev. 1997; 6: 783790.
  • 11
    Caraballo RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ, et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers. Third National Health and Examination Survey, 1988–1991. J Am Med Assoc. 1998; 280: 135139.
  • 12
    English PB, Eskenazi B, Christianson RE. Black–white differences in serum cotinine levels among pregnant women and subsequent effects on infant birthweight. Am J Public Health. 1994; 84: 14391443.
  • 13
    Carmella SG, Akerkar SA, Richie JP Jr., Hecht SS. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers's urine. Cancer Epidemiol Biomark Prev. 1995; 4: 635642.
  • 14
    Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 1988; 9: 875884.
  • 15
    Hecht SS. Biochemistry, biology and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 1998; 11: 559603.
  • 16
    Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999; 91: 11941210.
  • 17
    Upadhyaya P, Kenney PMJWM, Hochalter JB, Hecht SS. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) enantiomers and metabolites in the A/J mouse. Carcinogenesis. 1999; 20: 15771585.
  • 18
    Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003; 3: 733744.
  • 19
    Wynder EL, Muscat JE. The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect. 1995; Nov 103 Suppl 8: 143148.
  • 20
    Benowitz NL, Perez-Stable EJ, Fong I, Modin G, Herrera B, Jacob IIIP. Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther. 1999; 291: 11961203.
  • 21
    Westley J, Thiocyanate and thiosulfate. Methods Enzymol. 1987; 143: 2225.
  • 22
    Perez-Stable EJ, Herrera B, Jacob IIIP, Benowitz NL. Nicotine metabolism and intake in black and white smokers. J Am Med Assoc. 1998; 280: 152156.
  • 23
    Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987; 77: 14351438.
  • 24
    Velicer WF, Prochaska JO, Rossi JS, Snow MG. Assessing outcome in smoking cessation studies. Psychol Bull. 1992; 111: 2341.
  • 25
    Weiserbs KF, Jacobson JS, Begg MD, Wang LW, Wang Q, Agrawal M, et al. A cross-sectional study of polycyclic aromatic hydrocarbon-DNA adducts and polymorphism of glutathione S-transferases among heavy smokers by race/ethnicity. Biomarkers. 2003; 8: 142155.
  • 26
    Ren Q, Murphy SE, Zheng Z, Lazarus P. O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9. Drug Metab Dispos. 2000; 28: 135260.
  • 27
    Bendaly J, Fang JL, Wiener D, Lazarus P. Functional characterization of the UGT1A183Gly and UGT2B7268Tyr polymorphic variants. Scientific Program. 95th Annual Meeting of the American Association for Cancer Research. Orlando, Fl. March 27–31, 2004, p 218.
  • 28
    Anderson GD. Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase. J Gend Specif Med. 2002; 5: 2533.
  • 29
    Kassie F, Uhl M, Rabot S, Grasl-Kraupp B, Verkerk R, Kundi M, Chabicovsky M, et al. Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen. Carcinogenesis. 2003; 24: 255261.
  • 30
    van der Logt EM, Roelofs HM, Nagengast FM, Peters WH. Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis. 2003; 24: 16511656. E-pub 2003 Jul 17.
  • 31
    Le Bon AM, Vernevaut MF, Guenot L, Kahane R, Auger J, Arnault I, et al. Effects of garlic powders with varying alliin contents on hepatic drug metabolizing enzymes in rats. J Agric Food Chem. 2003; 51: 761723.
  • 32
    Hecht SS, Carmella SG, Kenney PM, Low SH, Arakawa K, Yu MC. Effects of cruciferous vegetable consumption on urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in Singapore Chinese. Cancer Epidemiol Biomarkers Prev. 2004; 13: 9971004.
  • 33
    Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis. 2002; 23: 907922.
  • 34
    Maser E, Richter E, Friebertshauser J. The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur J Biochem. 1996; 238: 484489.
  • 35
    Maser E. Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer? TIPS. 1997; 18: 270275.
  • 36
    Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht SS. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. J Natl Cancer Inst. 2001; 93: 378381.
  • 37
    Gadgeel SM, Kalemkerian GP. Racial differences in lung cancer. Cancer Metastasis Rev. 2003; 22: 3946.
  • 38
    Krieger N. Refiguring “race”: epidemiology, racialized biology, and biological expressions of race relations. Int J Health Serv. 2000; 30: 211216.
  • 39
    Feigelman W, Gorman B. Toward explaining the higher incidence of cigarette smoking among black Americans. J Psychoactive Drugs. 1989; 21: 299305.
  • 40
    Colby JP Jr, Linsky AS, Straus MA. Social stress and state-to-state differences in smoking and smoking related mortality in the United States. Soc Sci Med. 1994; 38: 373381.
  • 41
    Romano PS, Bloom J, Syme SL. Smoking, social support, and hassles in an urban African-American community. Am J Public Health. 1991; 81: 14151422.
  • 42
    Chang SI, Djordevic MV, Zhang J, Hosey J, Chen S, Tika M, et al. Cigarette smoking topography, delivered doses of smoke toxins, and excreted metabolites of smoke constituents: a comparison of African-American and white American smokers. Scientific Program. 95th Annual Meeting of the American Association for Cancer Research. Orlando, Fl. March 27–31, 2004, p 168.